共 201 条
- [1] Zhou SF(2009)Polymorphism of human cytochrome P450 enzymes and its clinical impact Drug Metab Rev 41 89-295
- [2] Liu JP(2003)Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population Eur J Clin Pharmacol 59 303-312
- [3] Chowbay B(2007)Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype–phenotype relationship in Swedes and Koreans Eur J Clin Pharmacol 63 537-546
- [4] Gaikovitch EA(2011)Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population Genet Test Mol Biomarkers 15 827-830
- [5] Cascorbi I(2011)Prevalence of CYP2C19 polymorphisms in the Lebanese population Mol Biol Rep 38 5449-5452
- [6] Mrozikiewicz PM(2006)CYP3A phenotypes and genotypes in North Indians Eur J Clin Pharmacol 62 417-422
- [7] Brockmoller J(2011)Effects of UDP-glucuronosyltransferase polymorphisms on the pharmacokinetics of ezetimibe in healthy subjects Eur J Clin Pharmacol 67 39-45
- [8] Frotschl R(2010)Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population Eur J Clin Pharmacol 66 999-1003
- [9] Kopke K(2011)Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on patients Int J Mol Med 28 1093-1102
- [10] Gerloff T(2010)Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients Transplant Proc 42 3459-3464